Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Figure 5 Flap endonuclease-1 enhances tumorigenic potential of pancreatic cancer cells in vivo.
A: Representative in vivo bioluminescence imaging of nude mice bearing subcutaneous xenograft tumors derived from PATU8988T cells with modified FEN1 expression (shFEN1 or shNC); B and C: Representative macroscopic images and quantitative weight analysis of subcutaneous xenograft tumors harvested from nude mice (n = 5 per group) subcutaneously injected with 1 × 107 PATU8988T cells (shFEN1 or shNC) in the axilla; D: Growth kinetics of subcutaneous xenograft tumors measured at indicated time points over the experimental period; E: Immunohistochemical analysis of Ki-67 expression in xenograft tumor sections, indicating proliferation index. Scale bar = 20 μm; F: Representative hematoxylin and eosin staining of xenograft tumor sections showing histological features. Scale bar = 50 μm (left panels) or 20 μm (right panels). aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Xia Y, Guo N, Zhu CL, Gao JY, Da MX. Flap endonuclease-1 promotes pancreatic cancer progression via AKT/mTOR signaling pathway. World J Gastrointest Oncol 2025; 17(7): 104402
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/104402.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.104402